ArticleThe Journal of clinical investigation2000

Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis.

R K Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.